1. Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokined activated killer cells in an intraperitoneal murine model;Eggermont;Br. J. Cancer,1988
2. Infiltration of interleukin-2-inducible killer cells in ascites fluid and pleural effusions of advanced cancer patients;Blanchard;Cancer Res.,1988
3. Chronic indomethacin therapy reverses PGE2-mediated suppression of IFN-γ development on lymphocytes of tumor-bearing mice and augments receptor development during therapy with IL-2, or IFN-γ or IFN-γ plus IL-2;Elkhashab,1988
4. Biological response modifiers the new immunotherapy;Foon;Cancer Res.,1989
5. Surface markers of small lymphocytes appearing in the mouse Ehrlich ascites tumor, host spleen and blood;Garnis;Immunology,1978